Most pages about kratom detox give you a timeline and a list of medications. This one cannot. The reason is worth knowing before you read further.
The National Institute on Drug Abuse states that withdrawal and substance use disorder symptoms related to kratom use have not been extensively studied. It also states that there are currently no approved medical therapies for these conditions [1]. So a page that hands you a day-by-day schedule for kratom has taken it from somewhere else. Usually from opioids, which is a different drug with a different course.
Federal sources do support a lot, though. What kratom is. What withdrawal reports look like so far. What the real risks are. And what a supervised setting offers when the drug itself is poorly understood. Our page on kratom covers the drug in more detail.
What kratom is, and why it acts like two drugs at once
Kratom is a tropical tree, Mitragyna speciosa, native to Southeast Asia, and products made from its leaves are sold online and in stores in the United States [2].
Two of its compounds do most of the work. Mitragynine and 7-hydroxymitragynine both activate mu-opioid receptors in the brain. But the resulting effects only partially compare to those of opioids such as heroin or oxycodone [1]. That “only partially” is the source’s own hedge, and it matters.
People report two different kinds of effect. Stimulant-like ones, such as increased energy, alertness and a rapid heart rate. And opioid- or sedative-like ones, such as relaxation, pain relief and confusion [3].
The scale is easy to underestimate. An estimated 1.7 million Americans aged 12 and older used kratom in 2021, in the federal National Survey on Drug Use and Health [2]. People often use it to self-treat pain, coughing, diarrhea, anxiety and depression. They also use it for opioid use disorder and opioid withdrawal [2].
One more thing about the product. Effects are hard to predict because kratom products vary. Some have been found to hold contaminants that produce effects kratom alone does not [1]. That is one reason this page gives no amounts.
What is known about kratom withdrawal, and what is not
Start with the sentence almost nobody quotes. Withdrawal and substance use disorder symptoms tied to kratom use have not been extensively studied, although some people who use kratom report having them [1].
What the studies suggest so far is modest and hedged. People may have mild to moderate withdrawal symptoms when they stop regular kratom use [1]. More research is needed to see how far people develop substance use disorder symptoms from it [1]. Early data from anonymous surveys suggest a minority of people report kratom-related withdrawal symptoms, and a smaller minority report substance use disorder symptoms [1].
The diagnostic picture is unsettled too. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders holds no specific diagnosis for kratom use [1]. Some researchers have adapted criteria from other substances in order to study it [1].
NCCIH gets to the same place from another direction. Very little research in people has evaluated the health effects of kratom [3]. It also notes that people may use kratom to try to overcome opioid addiction, while kratom itself may have the potential to be addictive [3]. Regular users may have withdrawal symptoms if they stop [3].
So this page gives no timeline. Not a peak, not a duration, not a day count. There is no federal source for one. Borrowing an opioid or stimulant figure would mean inventing a fact about a different drug. Our page on kratom withdrawal takes that question on directly, including why the evidence is thin, and our guide to withdrawal symptoms covers what withdrawal involves across substances.
Why there is no approved medication for it
The answer is short, and it has two halves.
There are currently no approved medical therapies for kratom withdrawal, or for substance use disorder symptoms tied to kratom use [1]. In very limited cases researchers have reported using medications and other therapies in people and animal models. But robust clinical trials are still needed to evaluate these and other experimental options [1].
The other half is about kratom itself as a medicine. There are no prescription or over-the-counter drug products holding kratom or its known alkaloids legally on the market in the United States [2]. NCCIH puts it plainly. Kratom has not been shown to be safe and effective for this or any other medical use [3].
That does not mean a person in withdrawal gets nothing. It means the care is built around assessment, monitoring and the symptoms in front of the clinician. It is not built around a protocol. Our explainer on medication-assisted treatment sets out where approved medications do exist, which is a useful contrast.
What a supervised setting does instead
Federal guidance calls withdrawal care a medical step that brings a person safely through acute withdrawal [4]. It breaks the work into three parts [4].
Evaluation comes first. It covers testing for substances, and screening for other mental and physical conditions [4]. It also takes in a full read of someone’s health and their situation at home, to decide what level of care should follow [4]. On a kratom admission that work matters more than usual. What someone has been taking, and what else was in it, is often unclear.
Stabilization is the middle part. It brings the person through acute withdrawal to a medically stable, fully supported state [4]. The third part is fostering the person’s entry into treatment [4]. That is the one that decides what the next year looks like.
The setting is a decision, not a default. Federal guidance sets out five levels of care for adults [5]. They run from an organized outpatient service, through outpatient care with nurses watching for several hours a day, to residential care, and then to round-the-clock medical care on an inpatient or acute unit [5]. Doctors are told to use prudence in deciding who can go through this safely as an outpatient [5]. As a general rule, outpatient care is just as effective as inpatient care for people with mild to moderate withdrawal symptoms [5].
Our pages on levels of care and medical detox set out what each tier involves.
The risks that make supervision worth considering
This is where the thin evidence stops being reassuring.
The Food and Drug Administration has warned consumers not to use kratom because of the risk of serious adverse events, including liver toxicity, seizures and substance use disorder [2]. NCCIH lists mild effects such as nausea, constipation, dizziness and drowsiness, alongside rare but serious effects including seizures, high blood pressure and liver problems [3].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Deaths need their hedge kept intact. Fatal overdoses from kratom alone appear to be extremely rare [3]. In the rare cases confirmed by a medical examiner or toxicology report, kratom was usually used with other drugs, and its part in the death is unclear [2]. NIDA says the same from its side. A very small number of deaths have been linked to kratom products, and nearly all cases involved other drugs or contaminants [1].
Breathing is worth one careful paragraph, because people assume the opposite. In general, neither kratom leaves nor mitragynine appear to lead to the respiratory depression that marks a life-threatening opioid overdose [1]. But in lab models, 7-hydroxymitragynine can cause respiratory depression that is reversed by naloxone [1]. And while it is only a small part of natural leaves, 7-hydroxymitragynine has much greater mu-opioid receptor potency than mitragynine, and than classical opioids such as morphine [2].
Then there is what is in the packet. The FDA has warned the public when kratom products were contaminated with Salmonella, or with concerning levels of heavy metals. It says those contaminants have resulted in numerous documented illnesses [2]. NCCIH reports the same kinds of contaminant [3].
Put those together and the case for supervision is not that withdrawal itself is known to be dangerous. It is that the drug is poorly understood, the product is unpredictable, and seizures and liver injury are on the list.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Pregnancy, newborns and a risk that is easy to miss
The FDA is aware of cases of neonatal abstinence syndrome. Newborns showed withdrawal signs such as jitteriness, irritability and muscle stiffness after long exposure to kratom before birth [2].
NIDA describes the same picture, and adds the part families need. In those cases the infants all responded well to the standard treatments given to infants with neonatal abstinence syndrome related to opioids [1].
No page should put a number on how often this happens, because none is published. What is worth saying is simpler. A clinician needs to know about kratom use in pregnancy, the same way they would need to know about any opioid. That is a reason to tell them, not a reason to wait.
After withdrawal: treatment, coverage and getting assessed
Getting through withdrawal is the start of the work, not the end of it.
Federal guidance says a detoxification program is not designed to resolve the longstanding psychological, social and behavioral problems tied to alcohol and drug use [4]. It says plainly that detoxification is not substance use treatment and rehabilitation [4]. Federal drug information puts the same point in one line. Most people need long-term treatment after detox [6].
That matters here for a reason. Many people who use kratom report doing so to self-treat something: pain, anxiety, depression, fatigue, or withdrawal from something else [1]. Whatever that something is, it does not vanish when the kratom does. Our pages on dual diagnosis care and what the treatment process is like cover how a program handles both at once. Inpatient rehab and outpatient rehab describe the two settings that follow.
Coverage is answered per plan and per level of care, not in general. Our pages on insurance coverage for rehab and what treatment costs explain the terms before a benefits call. How admission works sets out the steps, and our treatment centers lists the campuses we run.
When you call, say what you have actually been taking, including anything else alongside it. On this substance that is the single most useful thing you can bring to an assessment.
Frequently Asked Questions
What happens at a kratom detox assessment? Federal guidance describes the evaluation as testing for substances, screening for other mental and physical conditions, and a full read of someone’s medical and psychological condition and social situation, in order to decide the level of care that follows. On kratom that work matters more than usual, because products vary and what else was in them is often unclear.
How is kratom withdrawal managed in a detox program? Symptom by symptom, because no protocol exists. NIDA states that there are currently no approved medical therapies for kratom withdrawal or for substance use disorder symptoms related to kratom use. Researchers have reported using medications and other therapies in very limited cases, but robust clinical trials are still needed to evaluate them. Care is built around assessment, monitoring and the symptoms present rather than around a protocol.
Can kratom withdrawal be managed at home? That is an assessment decision, not a web page decision. Federal guidance says physicians should use prudence in determining who can undergo withdrawal management safely as an outpatient. The risks that argue for supervision here are seizures, liver toxicity and contaminated product. If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Is kratom an opioid? Not exactly, and the distinction is real. Its compounds mitragynine and 7-hydroxymitragynine both activate mu-opioid receptors, but the resulting effects only partially compare to those of opioids such as heroin or oxycodone. People report stimulant-like effects as well as opioid-like ones. Kratom is not on the federal schedule of controlled substances, though the DEA has listed it as a drug of concern.
When is kratom use a medical emergency? The FDA warns consumers not to use kratom because of the risk of serious adverse events, including liver toxicity, seizures and substance use disorder. NCCIH lists seizures, high blood pressure and liver problems among the rare but serious effects reported. If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Sources
- National Institute on Drug Abuse. (2026). Kratom. NIDA, National Institutes of Health. https://nida.nih.gov/research-topics/kratom
- U.S. Food and Drug Administration. (2025). FDA and Kratom. Public Health Focus. https://www.fda.gov/news-events/public-health-focus/fda-and-kratom
- National Center for Complementary and Integrative Health. (2022). Kratom. NCCIH, National Institutes of Health. https://www.nccih.nih.gov/health/kratom
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment — Chapter 1, Overview, Essential Concepts, and Definitions in Detoxification. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64119/
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment — Chapter 2, Settings, Levels of Care, and Patient Placement. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64109/
- MedlinePlus. Opiate and opioid withdrawal. Medical Encyclopedia, U.S. National Library of Medicine, National Institutes of Health. https://medlineplus.gov/ency/article/000949.htm
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
